FBIO

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics

05/30 10:47 am

Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference

05/07 08:00 am

Mustang Bio Announces Closing of $8 Million Public Offering

02/10 09:00 am

Mustang Bio Announces Pricing of $8 Million Public Offering

02/06 08:00 am

Mustang Bio Announces Pricing of $8 Million Public Offering

02/06 08:00 am

Fortress Biotech CEO buys $36.7k in preferred stock - Investing.com

07/10 08:41 am

Greenbrier, Fortress Biotech And 3 Stocks To Watch Heading Into Monday - Greenbrier Companies (NYSE:GBX) - Benzinga

07/08 03:10 am

Checkpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

07/02 08:00 am

Checkpoint Therapeutics Announces Biologics License Application Resubmission for Cosibelimab

07/02 07:00 am

Checkpoint Therapeutics Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA Resubmission

06/24 07:30 am

Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

05/16 08:00 am

Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

05/15 04:15 pm

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

05/15 04:01 pm

AquaBounty Technologies, Inc. (AQB) Reports Q1 Loss, Misses Revenue Estimates

05/15 10:20 am

Ovid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates

05/14 09:10 am

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

05/13 04:01 pm

Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

05/13 08:30 am

Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates

05/10 08:30 am

Aveanna Healthcare (AVAH) Reports Q1 Loss, Tops Revenue Estimates

05/09 07:40 am

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

05/07 08:30 am

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

04/25 08:30 am

Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights

03/28 04:05 pm

Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

03/22 08:30 am

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

03/21 04:01 pm

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

03/18 08:30 am

Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024

03/15 08:30 am

Journey Medical Corporation to Participate in the 36th Annual ROTH Conference

03/13 08:30 am

Fortress Biotech to Participate in 36th Annual ROTH Conference

03/12 08:30 am

Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting

03/11 08:30 am

Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease

03/04 09:30 am

Alzamend Neuro And 3 Other Stocks Under $3 Insiders Are Buying

01/10 09:09 am

Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea

01/05 09:30 am

Fortress Biotech Announces Closing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

01/03 05:01 pm

Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million

01/02 05:05 pm

Fear & Greed Index Remains In 'Extreme Greed' Zone; S&P 500 Surges 24% In 2023

01/02 03:32 am

Gold Moves Lower; Microbot Medical Shares Slide

12/29 03:21 pm

Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session

12/29 02:03 pm

Nasdaq Down Over 100 Points; Fortress Biotech Shares Plummet

12/29 01:19 pm

Fortress Biotech Announces Pricing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

12/29 09:20 am

Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session

12/18 02:05 pm

Cyprium Therapeutics, a Fortress Biotech Subsidiary Company, Completes Asset Transfer of CUTX-101 Copper Histidinate Product Candidate for Treatment of Menkes Disease, to Sentynl Therapeutics, a Wholly-owned Subsidiary of Zydus Lifesciences Ltd.

12/06 09:30 am

Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea

12/06 09:00 am

Roth MKM Maintains Buy Rating for Fortress Biotech: Here's What You Need To Know

11/29 01:00 pm

Best Penny Stocks To Buy This Week? 4 To Watch Now

11/20 11:17 am

11 Top Penny Stocks To Buy Now According To Insiders

11/17 02:32 pm

Fortress Biotech Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

11/14 05:10 pm

Fortress Biotech Announces Closing of $10.0 Million Public Offering

11/14 05:01 pm

Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session

11/10 02:34 pm

Dow Gains Over 100 Points; Wynn Resorts Earnings Top Views

11/10 10:48 am

Fortress Biotech Announces Pricing of $10.0 Million Public Offering

11/10 09:15 am